AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2014
Sep 25, 2014
3174_iss_2014-09-25_c5f9740e-d5c6-405b-a366-37377721d21b.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Bure Equity AB (publ)
Instrument
| Instrument | Aktie SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | 710,000 | |
| Voting rights | 710,000 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 24/09/2014 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 0 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 0 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||||
|---|---|---|---|---|---|
| Shares | |||||
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first Instruments - FITA Ch. 4, section 2, first paragraph, line 3 - Physically settled |
||||
| - Cash settled Total |
|||||
| Published | |||||
| 25/09/2014 13:01 | |||||
| Contact Name Phone |
Max Jonson | 08-6140020 Email [email protected] | |||
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13